Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04004065
Brief Title: A Phase 2 Study for Dose Determination of SRP-5051, Then Dose Expansion in Patients With Duchenne Muscular Dystrophy Amenable to Exon 51-Skipping Treatment (MOMENTUM)

First Submitted : June 27, 2019
First Submitted that Met QC Criteria : June 27, 2019
First Posted : July 1, 2019

Last Update Submitted that Met QC Criteria : June 27, 2019
Last Update Posted : July 1, 2019